Clinical Trials Browser

Phase 4 × INDUSTRY × carfilzomib × Clear all

NCT03934684 2025-08-06

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

Phase 4 Completed

101 enrolled 11 charts

Multiple Myeloma